Esthesioneuroblastoma: What is the Optimal Treatment?

REFERENCES

• Nelson RS, Pearlman EJ, Askin F. Is esthesioneuroblastoma a peripheral neuroectodermal tumor? Hum Pathol 1995; 26: 639–41.
   Google Scholar
• Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the disease published since the discovery of the tumor in 1924. Anticancer Research 1997; 17: 2683–706.
   Google Scholar
• Svane-Knudsen V, Joergensen KE, Hansen O, Lindgren A, Marker P. Cancer of the nasal cavity and paranasal sinuses: a series of 115 patients. Rhinology 1998; 36: 12–4.
   Google Scholar
• Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma: a clinical analysis of 17 cases. Cancer 1976; 37: 1571–6.
   Google Scholar
• Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and manage-ment. Neurosurgery 1993; 32: 706–15.
   PubMed Web of Science ®Google Scholar
• Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC. Esthesioneuroblastoma. Cancer 1979; 44: 1087–94.
   PubMed Web of Science ®Google Scholar
• Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 1992; 102: 843–9.
   PubMed Web of Science ®Google Scholar
• Spaulding CA, Kranyak MS, Constable WC, Stewart FM. Esthesioneuroblastoma: a comparison of two treatment eras. Int J Radiat Oncol Biol Phys 1988; 15: 581–90.
   PubMed Web of Science ®Google Scholar
• Foote RL, Morita A, Ebersold MJ, et al. Esthesioneuroblas-toma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 1993; 27: 835–42.
   PubMed Web of Science ®Google Scholar
• Eden BV, Debo RF, Lamer JM, et al. Esthesioneuroblas-toma-long term outcome and patterns of failure-the Uni-versity of Virginia experience. Cancer 1994; 73: 2556–62.
   PubMedGoogle Scholar
• Beitler JJ, Fass DE, Brenner HA, et al. Esthesioneuroblas-toma: is there a role for elective neck treatment? Head Neck 1991; Jul/Aug: 321–6.
   Google Scholar
• Hirose T, Scheithauer BW, Lopes MBS, et al. Olfactory neuroblastoma-an immunohistochemical, ultrastructural and flow cytometric study. Cancer 1995; 76: 4–19.
   PubMedGoogle Scholar
• Wong WS, Tattersall MH. Immunohistochemical determina-tion of tumor growth fraction in human ovarian tumors. Br J Obstet Gynaecol 1989; 96: 720–4.
   PubMedGoogle Scholar
• Gasparini G, Pozza F, Meli S, Reitano M, Bevilacqua P. Breast cancer kinetics: immunocytochemical determination of growth fractions by monoclonal antibody KI-67 and correla-tion with flow cytometric S-phase and with some features of tumor aggressiveness. Anticancer Res 1991; 11: 2015–21.
   Google Scholar
• Shaari CM, Catalano PJ, Sen C, Post K. Central nervous system metastases from esthesioneuroblastoma. Otolaryngol Head Neck Surg 1996; 114: 808–12.
   PubMedGoogle Scholar
• Guedea F, Van Limbergen E, Van Den Bogaert W. High dose level radiation therapy for local tumor control in esthesioneu-roblastoma. Eur J Cancer 1994; 30A: 1757–60.
   PubMedGoogle Scholar
• Jekunen AP, Kairemo KJA, Lehtonen HP, Kajanti MJ. Treatment of olfactory neuroblastoma-a report of 11 cases. Am J Clin Oncol 1996; 19: 375–8.
   PubMedGoogle Scholar
• Homize MJ, Elkon D. Olfactory esthesioneuroblastoma-variables predictive of tumor control and recurrence. Cancer 1980; 46: 2509–13.
   PubMedGoogle Scholar
• McCaffrey TV, Olsen KD, Yohanan JM, Lewis JE, Ebersold MJ, Piepgras DG. Factors affecting survival of patients with tumors of the anterior skull base. Laryngoscope 1994; 104: 940–5.
   PubMedGoogle Scholar
• Kempf HG, Becker G, Weber PD, Ruck P. Diagnostik und therapie des Olfaktoriusneuroblastoms. HNO 1994; 42: 422–8.
   PubMedGoogle Scholar
• Feyerabend T. Die stellung der radiotherapie in der behand-lung des aesthesioneuroblastoms. HNO 1990; 38: 20–3.
   PubMedGoogle Scholar
• Bhattacharyya N, Thornton A, Joseph MP, Goodman ML, Amrein PC. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Arch Otol Head Neck Surg 1997; 123: 34–40.
   Google Scholar
• Million RR, Cassisi NJ. Management of Head and Neck Cancer. 2nd ed. Philadelphia: JB Lippencott Co, 1994: 575–86.
   Google Scholar
• Levine PA, Debo RF, Meredith SD, Jane JA, Constable WC, Cantrell RW. Craniofacial resection at the University of Virginia (1976–1992): survival analysis. Head Neck 1994; Nov-Dec: 574–7.
   Google Scholar
• Goldsweig HG, Sundaresan N. Chemotherapy of recurrent esthesioneuroblastoma-case report and review of the litera-ture. Am J Clin Oncol 1990; 13: 39–43.
   PubMedGoogle Scholar
• Jacob HE. Chemotherapy for cranial base tumors. J Neuro Oncol 1994; 20: 327–35.
   PubMedGoogle Scholar
• Levine PA, McLean WC, Cantrell RW. Esthesioneuroblas-toma: the University of Virginia experience 1960-1985. Laryngoscope 1986; 96: 742–6.
   Google Scholar
• Zaleska-Czepko E, Cwiklinska M, Balwierz W, Armata J. Successful multidrug chemotherapy of olfactory neuroblas-toma in a 8-year-old child. Ped Haematol Oncol 1996; 13: 191–3.
   Google Scholar
• Stewart FM, Lazarus HM, Levine PA, Stewart KA, Tabbara IA, Spaulding CA. High-dose chemotherapy and autologous marrow transplantation for esthesioneuroblastoma and sinonasal undifferentiated carcinoma. Am J Clin Ocol 1989; 12: 217–21.
   PubMedGoogle Scholar
• Newbill ET, Johns ME, Cantrell RW. Esthesioneuroblas-toma-diagnosis and management. South Med J 1985; 78: 275–82.
   PubMedGoogle Scholar
• Shah JP, Feghali J. Esthesioneuroblastoma. CA-A Cancer J Clin 1983; 33: 154–9.
   PubMed Web of Science ®Google Scholar
• Spiro JD, Soo KC, Spiro RH. Nonsquamous cell malignant neoplasms of the nasal cavities and paranasal sinuses. Head Neck 1995; March/April: 114–8.
   Google Scholar
• Strnad V, Grabenbauer GG, Dunst J, Sauer R. Radiotherapie beim aesthesioneuroblastom. Strahlenther Onkol 1994; 170: 79–84.
   PubMedGoogle Scholar